Podcasts and Videos

Dear ECCO Friends and Community, It is our pleasure to present a new Meet the Reps interview, this time featuring Austria’s ECCO National Representative, Andreas Blesl.

Dear ECCO Friends and Family, In this new episode of Meet the JCC Authors, I had the pleasure of speaking with Sara El Ouali about her recent publication in the Journal of Crohn’s and Colitis titled: “Ustekinumab for ileal stricturing Crohn’s disease—an international multicenter retrospective cohort study.”

Dear ECCO Family, In this interview, I had the pleasure of speaking with Professor Tarkan Karakan, an experienced clinician working in inflammatory bowel disease in a low- and middle-income country setting. Our conversation explored the practical realities of diagnosing and managing IBD, including limited healthcare resources, access to advanced therapies, and diagnostic infrastructure.

Dear ECCO friends and family, It is with great pleasure that I am sharing with you our discussion with the ECCO National Representative of Poland Piotr Eder. We had a great discussion on a variety of topics such as the current landscape regarding IBD management in Poland, including the situation concerning access to advanced treatments and calprotectin as a biomarker, the first steps of intestinal ultrasound spreading in the country but also the existing differences in training and managing complex cases between countries in Eastern and Western Europe.

Dear ECCO friends and family, Welcome to this stimulating discussion with Dr. Alejandra Carriles and Dr. Benedetta Ricchi authors of the exciting paper “From Pharmaceutical to Biophysical Therapies: New Horizons in Inflammatory Bowel Disease Management”. We had a great time conversing about what biophysical therapies might be used in IBD patient management, where these may fit in the current therapeutic landscape based on the evidence available and what made them explore this not well-known area of treatment.

Dear ECCO Friends and Family, In this episode of ECCO News “Meet the JCC Plus Authors”, we speak with Dr. Thea Helm Wiken and Dr. Karoline Anisdahl about their recent study comparing vedolizumab and ustekinumab in TNF inhibitor–experienced ulcerative colitis patients. Drawing on real-world data and a therapeutic drug monitoring approach, the study provides valuable insights into treatment effectiveness, timing of response, and the role of dose optimization in clinical practice.

Dear ECCO Family, In this interview, I had the pleasure of speaking with Professor Tarkan Karakan, an experienced clinician working in inflammatory bowel disease in a low- and middle-income country setting. Our conversation explored the practical realities of diagnosing and managing IBD, including limited healthcare resources, access to advanced therapies, and diagnostic infrastructure.

Dear ECCO Family, In this interview, Nicolas Avellaneda had the pleasure of speaking with Karin Davidson, a nurse from South Africa who participated in the development of the ECCO consensus on the management of inflammatory bowel disease (IBD) in low- and middle-income countries (LMICs).

Dear ECCO Friends and Family, In this new episode of Meet the JCC Authors, I had the pleasure of speaking with Sara El Ouali about her recent publication in the Journal of Crohn’s and Colitis titled: “Ustekinumab for ileal stricturing Crohn’s disease—an international multicenter retrospective cohort study.”

Dear ECCO Friends and Community, In this new episode of ECCO News – Meet the Reps I had the pleasure of speaking with Prof. Juozas Kupčinskas, IBD National Representative for Lithuania, about his role within ECCO and his perspectives on advancing IBD care and research at both national and European levels.

Dear ECCO Family, In this interview, I had the pleasure of speaking with Dr. Vishal Sharma, JCC Plus Associate Editor, about his editorial journey, vision for the journal, and insights into the evolving landscape of inflammatory bowel disease research.

Dear ECCO Friends and Family, In this new episode of Meet the JCC Authors, I had the pleasure of speaking with Dr. Sudheer K. Vuyyuru about his recent publication in the Journal of Crohn’s and Colitis, titled: "Day 3 Oxford Criteria Predict Steroid Non-response for Acute Severe Ulcerative Colitis in the Post Biologic Era."

Dear ECCO friends and family, welcome to this interesting discussion with Dr. Tian Hong Wu first author of the exciting paper “Natural History of Crohn’s Disease Leading to Intestinal Failure: A Longitudinal Cohort Study from 1973 to 2018”.

Dear ECCO Friends and Community, It is our pleasure to present our conversation with Armenia’s ECCO National Representatives, Manik Gemilyan and Edmond Baghdasaryan. In this video, we aim to provide an insightful overview of the evolving landscape of IBD care in Armenia, highlighting current challenges, progress, and the aspirations of the local medical community.

We had the pleasure to talk with Raja Atreya and Dominik Bettenworth in a wide-rage conversations covering aspects on the current status of IBD care in Germany, current Research Projects of the German IBD Society and more

Dear ECCO friends and family, welcome to this interesting discussion with Dr. Tian Hong Wu first author of the exciting paper “Natural History of Crohn’s Disease Leading to Intestinal Failure: A Longitudinal Cohort Study from 1973 to 2018”.

Dear ECCO colleagues We are delighted to bring a different colour to our Autumn edition of ECCO News interview corner as we meet and get to know another talented JCC author.

Dear ECCO friends and family, It is with great pleasure that I am sharing with you our discussion with the ECCO National Representatives of Latvia Jelena Derova and Aleksejs Derovs.

Dear ECCO friends and family, It is my pleasure to introduce the ECCO National Representatives of Malta Martina Sciberras and Pierre Ellul. We had a great discussion on a variety of topics such as the challenges of treating IBD in Malta, how working with a small but excellently followed cohort of patients can be a strength, how the Maltese Group of IBD is not only importing all newest developments such as intestinal ultrasound but also paving the way for younger colleagues to train and hone their skills abroad and much more!

Dear ECCO Friends, Welcome to this new episode of the Meet the JCC Authors Podcast! Here, we interview the rising star of intestinal ultrasound (IUS), Michael Dolinger from Mount Sinai Hospital (NY, US), about his recent article in JCC entitled: “Early intestinal ultrasound response to biologic therapy predicts endoscopic remission in children with ileal Crohn's Disease: Results from the Prospective Super Sonic Study”.